With a blood pressure of 157/68 mmHg while taking losartan 100 mg daily, should I add amlodipine (calcium‑channel blocker) to the regimen?

Yes, add amlodipine to your losartan 100mg regimen

With a blood pressure of 157/68 mmHg on losartan 100mg monotherapy, you should add a dihydropyridine calcium channel blocker (amlodipine) as the next step in your treatment algorithm. Your systolic blood pressure remains significantly above target despite maximum-dose ARB therapy, making combination therapy the appropriate next intervention.

Why Add Amlodipine Now

Your current BP of 157/68 mmHg indicates:

• Systolic BP is 17-27 mmHg above target (targets range from 130-140 mmHg depending on your risk factors) 1, 2
• You're already on maximum-dose losartan (100mg) 3
• You have isolated systolic hypertension (elevated systolic with normal diastolic), which is particularly responsive to calcium channel blockers

The 2020 International Society of Hypertension guidelines provide a clear stepwise algorithm for non-Black patients 1:

1. Start with low-dose ACE inhibitor/ARB (you've done this)
2. Add a DHP-CCB (this is where you are now)
3. Increase to full doses
4. Add a thiazide/thiazide-like diuretic if still uncontrolled

The Evidence for ARB + CCB Combination

Adding amlodipine to losartan is strongly supported by guideline recommendations and clinical evidence:

• The 2024 ESC guidelines explicitly recommend ARB + dihydropyridine CCB as a preferred first-line combination 2
• The 2020 ISH guidelines position DHP-CCB as the second drug after ARB monotherapy for non-Black patients 1
• Research demonstrates that losartan/amlodipine combinations produce clinically significant additional BP reductions of 11-15 mmHg systolic when added to ARB monotherapy 4, 5

Amlodipine vs. Adding a Diuretic

While you could alternatively add hydrochlorothiazide, amlodipine is the superior choice in your situation for several reasons:

Metabolic advantages:

• The losartan/amlodipine combination reduces serum uric acid levels (mean decrease 1.9 mg/dL), while losartan/HCTZ increases uric acid 6
• No adverse effects on glucose or lipid metabolism with amlodipine 7
• HCTZ can worsen metabolic parameters 8

Efficacy in isolated systolic hypertension:

• Your BP pattern (157/68) represents isolated systolic hypertension
• Amlodipine-based regimens are particularly effective for this pattern 9
• Studies show comparable or superior systolic BP reduction with losartan/amlodipine vs. losartan/HCTZ 4

Tolerability profile:

• When combined with losartan, amlodipine has a 4-fold lower incidence of peripheral edema compared to amlodipine monotherapy 7
• Drug-related adverse events: 25.5% with losartan/amlodipine vs. 43.8% with amlodipine alone 9
• The ARB component mitigates the edema typically seen with CCBs

Practical Dosing Recommendations

Start with amlodipine 5mg once daily added to your current losartan 100mg 3:

• This combination (losartan 100mg + amlodipine 5mg) produces mean BP reductions of approximately 11-15/5-9 mmHg beyond losartan alone 4, 5
• If BP remains >140/90 mmHg after 4 weeks, increase amlodipine to 10mg daily 2, 10
• Consider a single-pill combination product to improve adherence 1, 2

Expected timeline:

• Significant BP reduction within 1-2 months 5
• Achieve target BP (<130-140/80-90 mmHg) within 3 months 1

Important Considerations

Your diastolic BP of 68 mmHg warrants attention:

• This is already at the lower end of acceptable
• Amlodipine will lower both systolic and diastolic BP, though the systolic reduction is typically greater
• Monitor for symptoms of hypotension (dizziness, lightheadedness)
• If diastolic drops below 60 mmHg or you develop symptoms, discuss dose adjustment with your physician

If BP remains uncontrolled after losartan 100mg + amlodipine 10mg:

• The next step would be adding a thiazide-like diuretic (chlorthalidone or indapamide preferred over HCTZ) 1, 2
• Consider evaluation for secondary hypertension if resistant to triple therapy
• Assess medication adherence

Common pitfalls to avoid:

• Don't combine losartan with another ARB or ACE inhibitor 2, 11
• Don't use immediate-release nifedipine (use long-acting CCBs only) 12
• Don't delay treatment intensification—uncontrolled hypertension increases cardiovascular risk

The combination of losartan and amlodipine is evidence-based, guideline-recommended, metabolically neutral, and specifically effective for your BP pattern. This represents the logical next step in your hypertension management algorithm.